These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36967806)

  • 1. Corrigendum: Depiction of immune heterogeneity of peripheral blood from patients with type II diabetic nephropathy based on mass cytometry.
    Jin J; Wang L; Liu Y; He W; Zheng D; Ni Y; He Q
    Front Endocrinol (Lausanne); 2023; 14():1168889. PubMed ID: 36967806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depiction of immune heterogeneity of peripheral blood from patients with type II diabetic nephropathy based on mass cytometry.
    Jin J; Wang L; Liu Y; He W; Zheng D; Ni Y; He Q
    Front Endocrinol (Lausanne); 2022; 13():1018608. PubMed ID: 36686486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum: Coffee intake and risk of diabetic nephropathy: a Mendelian randomization study.
    Fang J; Song K; Zhang D; Liang Y; Zhao H; Jin J; He Q
    Front Endocrinol (Lausanne); 2023; 14():1285535. PubMed ID: 37780609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Ankle-Brachial Index Is Independently Associated With Cardiovascular Outcomes and Foot Ulcers in Asian Patients With Type 2 Diabetes Mellitus.
    Yang MC; Huang YY; Hsieh SH; Sun JH; Wang CC; Lin CH
    Front Endocrinol (Lausanne); 2022; 13():878492. PubMed ID: 35370979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased secretion of TGF-beta1 by peripheral blood mononuclear cells from patients with Type 1 diabetes mellitus with diabetic nephropathy.
    Korpinen E; Groop PH; Fagerudd JA; Teppo AM; Akerblom HK; Vaarala O
    Diabet Med; 2001 Feb; 18(2):121-5. PubMed ID: 11251675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum: Association between hemoglobin glycation index and diabetic kidney disease in type 2 diabetes mellitus in China: a cross-sectional inpatient study.
    Xin S; Zhao X; Ding J; Zhang X
    Front Endocrinol (Lausanne); 2023; 14():1199643. PubMed ID: 37274333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB.
    Hofmann MA; Schiekofer S; Isermann B; Kanitz M; Henkels M; Joswig M; Treusch A; Morcos M; Weiss T; Borcea V; Abdel Khalek AK; Amiral J; Tritschler H; Ritz E; Wahl P; Ziegler R; Bierhaus A; Nawroth PP
    Diabetologia; 1999 Feb; 42(2):222-32. PubMed ID: 10064103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: Altered Gray Matter Volume in Patients With Type 1 Diabetes Mellitus.
    Liu J; Fan W; Jia Y; Su X; Wu W; Long X; Sun X; Liu J; Sun W; Zhang T; Gong Q; Shi H; Zhu Q; Wang J
    Front Endocrinol (Lausanne); 2020; 11():604. PubMed ID: 32982986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum: Vascular endothelial growth factor levels in diabetic peripheral neuropathy: a systematic review and meta-analysis.
    Ding R; Zhu S; Zhao X; Yue R
    Front Endocrinol (Lausanne); 2023; 14():1238758. PubMed ID: 37645412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating factors in sera or peripheral blood mononuclear cells in patients with membranous nephropathy or diabetic nephropathy.
    Ihm CG; Park JK; Hong SP; Lee TW; Cho BS; Kim MJ
    J Korean Med Sci; 1997 Dec; 12(6):539-44. PubMed ID: 9443093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum: Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis.
    Lian J; Fu J
    Front Endocrinol (Lausanne); 2022; 13():840299. PubMed ID: 35250889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression pattern of genes in peripheral blood mononuclear cells in diabetic nephropathy.
    Moczulski DK; Fojcik H; Wielgorecki A; Trautsolt W; Gawlik B; Kosiorz-Gorczynska S; Oczko-Wojciechowska M; Wiench M; Strojek K; Zukowska-Szczechowska E; Grzeszczak W
    Diabet Med; 2007 Mar; 24(3):266-71. PubMed ID: 17263765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum: The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus.
    Dong Y; Liu J; Ma J; Quan J; Bao Y; Cui Y
    Front Endocrinol (Lausanne); 2022; 13():1046738. PubMed ID: 36339417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: Implementation of a patient-centered remote wound monitoring system for management of diabetic foot ulcers.
    Keegan AC; Bose S; McDermott KM; Starks White MP; Stonko DP; Jeddah D; Lev-Ari E; Rutkowski J; Sherman R; Abularrage CJ; Selvin E; Hicks CW
    Front Endocrinol (Lausanne); 2023; 14():1235970. PubMed ID: 37424861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum: Placental Nutrient Transport in Gestational Diabetic Pregnancies.
    Castillo-Castrejon M; Powell TL
    Front Endocrinol (Lausanne); 2019; 10():5. PubMed ID: 30745893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: Application of the distally based sural neurocutaneous flaps in the management of foot and ankle defects in patients with diabetic foot.
    Dai J; Zhou Y; Mei S; Chen H
    Front Endocrinol (Lausanne); 2022; 13():1054322. PubMed ID: 36506066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum: Determinants of poor glycemic control among type 2 diabetes mellitus patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: Unmatched case-control study.
    Legese GL; Asres G; Alemu S; Yesuf T; Tesfaye YA; Amare T
    Front Endocrinol (Lausanne); 2023; 14():1220605. PubMed ID: 37415661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum: Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications.
    Willmer T; Johnson R; Louw J; Pheiffer C
    Front Endocrinol (Lausanne); 2019; 10():1. PubMed ID: 30723457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum: MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy.
    Zhou H; Ni WJ; Meng XM; Tang LQ
    Front Cell Dev Biol; 2022; 10():875280. PubMed ID: 35300423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum: The value of HDL subfractions in predicting cardiovascular outcomes in untreated, diabetic patients with stable coronary artery disease: an age- and gender-matched case-control study.
    Zhang W; Jin JL; Zhang HW; Zhu YX; Dong Q; Sun J; Guo YL; Dou KF; Xu RX; Li JJ
    Front Endocrinol (Lausanne); 2023; 14():1208564. PubMed ID: 37334289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.